Publication: Sarcoid-like reaction in breast cancer: A long-term follow-up series of eight patients
3
item.page.dc.date.issued
2012-02-01
item.page.dc.type
item.page.dc.identifier.issn
14362813
09411291
09411291
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-84857646554
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Surgery Today. Vol.42, No.3 (2012), 259-263
punsarn.item.page.citation
Stefano Martella, Visnu Lohsiriwat, Daniel Meirelles Barbalho, Paolo Della Vigna, Luca Bottiglieri, Tito Brambullo, Alessandra Gottardi, Mario Rietjens, Jean Yves Petit Sarcoid-like reaction in breast cancer: A long-term follow-up series of eight patients. Surgery Today. Vol.42, No.3 (2012), 259-263. doi:10.1007/s00595-011-0084-6 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/14997
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Sarcoid-like reaction in breast cancer: A long-term follow-up series of eight patients
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
Purpose: Finding an intrathoracic or axillary mass in a breast cancer patient should raise suspicion of a pulmonary or mediastinal nodal metastasis or axillary recurrence. Surprisingly, noncaseating epithelioid cell granuloma can be found in this type of lesion, as in sarcoidosis or a sarcoid-like reaction. Methods: This series included eight breast cancer patients in whom a late sarcoid-like reaction developed: as an intrathoracic lesion in six, and as an ipsilateral axillary lesion in two. The latency period from oncological surgery to the diagnosis of sarcoidosis was 40 months and the average follow-up after the diagnosis of sarcoidosis was 63.38 months. Results: None of the patients suffered relapse or oncological events during the period of this study. Conclusion: To avoid misdiagnosis and overtreatment, pathological examination should always be carried out. We do not recommend any specific treatment for sarcoidosis in a breast cancer patient, but routine oncological follow-up is appropriate. A larger series with statistical analysis is necessary to evaluate the prognosis. © 2011 Springer.
